Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB-1, and an immunohistochemical study

Analytical Cellular Pathology

Volumn 21, Issue 1, 2000, Pages 21-33

  Leonardi, Elena ^a   Palma, Paolo Dalla ^a   Reich, Alessandro ^a   Caffo, Orazio ^a   Luciani, Lucio ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Bladder cancer; Cell proliferation; DNA content; MIB 1; P53

Indexed keywords

BIOCHEMICAL MARKER; CYTOKERATIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; CANCER STAGING; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA CONTENT; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 0034489526     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/672354     Document Type: Article

References (45)

1. Identification of S-phase cells with PC10 antibody to proliferating cell nuclear antigen (PCNA) by flow cytometric analysis
2. Clinical evaluation of Cell deoxyribonucleic acid measured by flow cytometry in bladder cancer
3. Proliferation in human bladder carcinoma measured by Ki-67antibody labelling: Its potential clinical importance
4. Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of Sphase cells in cell cultures
5. Assessing genetic markers of tumour progression in the context of intratumour heterogeneity
6. Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract
7. Proliferation markers in tumours: Interpretation and clinical value
8. A model of DNA aneuploidization and evolution in colorectal cancer
9. Aneuploidy mechanisms in human colorectal preneoplastic lesions and Barrett's esophagus. Is there a role for K-ras and P53 mutations?
10. Proliferative pattern of exophytic and superficially invasive and noninvasive low-grade urothelial carcinomas
11. The relationship among multiple recurrences, progression and prognosis of patients with stages TA and T1 transitional cell cancer of the bladder followed for at least 20 years
12. P53 protein accumulation in superficial bladder cancer is predictor of subsequent muscle invasion
13. Characterisation of bladder tumours by multiparameter flow cytometry with special reference to grade II tumours
14. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer
15. Washless double staining analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine)
16. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: Evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis
17. Bivariate analysis DNA/cytokeratin and flow cytometric measurement of MIB-1 in superficial transitional carcinoma of the bladder (TCC). Methodological aspects and prognostic implications
18. Flow cytometric DNA/cytokeratin analysis of bladder lavage: Methodical aspects and clinical implications
19. Progression and survival in transitional cell bladder cancer: A comparison of established prognostic factors, S-phase fraction and DNA ploidy
20. Over-expression of p53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value
21. Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer
22. Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer
23. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: A prospective comparative study
24. Editorial: Superficial bladder cancer - Incremental insight
25. Cell proliferation and ploidy of human solid tumours: Methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry
26. p53 gene mutations in human urothelial carcinomas: Analysis by immunohistochemistry and single-strand conformation polymorphism
27. Increased cell division as a cause of human cancer
28. p53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer
29. Image analysis of in situ cell cycle related changes of PCNA and Ki67 proliferating antigen expression
30. Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder
31. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder
32. Model for the genetic evolution of human solid tumors
33. Origins and clinical implications of aneuploidy in early bladder cancer
34. Common patterns of genetic evolution in human solid tumors
35. Antigen retrieval in formalin fixed, paraffin embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
36. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder
37. Managing superficial bladder cancer: An overview
38. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms
39. Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients
40. Prognostic significance of DNA content in bladder cancer on flow cytometric analysis of 249 transitional cell carcinomas
41. Consensus review of the clinical utility of DNA cytometry in bladder cancer
42. DNA-flow cytometric analysis of bladder TCC using paraffinembedded tissue
43. Two-colormultiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocytecommon antigen
44. Correlation and prognostic significance of p53, p21 WAF/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with Bacillus Calmette-Guerin intravescical therapy
45. A comparison of different methods to determine cell proliferation by flow cytometry